Aquestive Therapeutics (AQST) stock gains as the company completes its marketing application for Anaphylm, an emergency treatment for allergic reactions. Read more here.

2-Year U.S. Treasury Note Continuous Contract $103.668 0.082 0.08% 5-Year U.S. Treasury Note Continuous Contract $108.445 0.289 0.27% 10-Year U.S. Treasury Note Continuous Contract $111.750 0.531 ...

Western Midstream Partners L.P. 1.02% $15.65B ...

Real time quote data is not available at this time. *Data is provided by Barchart.com. Data reflects weightings calculated at the beginning of each month. Data is subject to change. **Green ...